Download Nur 211 exam 3 with verified detailed answers and more Exams Nursing in PDF only on Docsity!
Nur || 211 || exam || 3 || with || verified || detailed || answers
Sickle || cell || anemia || predisposition || - || ✔✔African || american Central || africa The || near || east Mesiterranean Aboriginals Hispanics || (caribbean, || central || and || south || america) Sickle || cell || anemia || clinical || manifestations || - || ✔✔Fatigue Weakness Pain Swelling Tachycardia Murmur || Enlargement || of || bones || in || face || and || skull Sickle || cell || how || to || diagnosis || - || ✔✔CBC || - || low || hematocrit || Hgb || electrophoresis What || is || sickle || cell || acute || Vaso-occlusive || crisis? || - || ✔✔Very || painful, || rbc || and || WBC || entrapment || causing || tissue || hypoxia, || inflammation, || and || necrosis || due || to || inadequate || blood || flow What || is || sickle || cell || aplastic || crisis? || - || ✔✔Due || to || parvovirus, || rapid || fall || in || HgB || were || bone || marrow || cannot || compensate
What || is || sickle || cell || sequestration || crisis? || - || ✔✔Other || organs || (specifically || spleen) || affected || by || pooling || of || sickle || cells What || triggers || a || sickle || cell || crisis? || - || ✔✔Illness Stress Alcohol Dehydration || Cold || weather High || altitude Complications || of || sickle || cell || anemia || - || ✔✔Anemia, || Pulmonary || hypertension, || Acute || chest || syndrome, || heart/renal || failure, || CVA/Stroke, || infection, || leg || ulcers, || eye || damage, || substance || abuse How || do || you || treat || sickle || cell || anemia? || - || ✔✔Management || of || symptoms, || therapies || (rx, || procedural, || supportive) What || are || procedural || therapies || to || treat || sickle || cell || anemia? || - || ✔✔Hematopoietic || stem || cell || transplantation, || transcranial || doppler || studies What || RX || therapy || is || used || to || treat || sickle || cell || anemia? || - || ✔✔Hydroxyurea Nsaids Morphine Opioids Antibiotics || (pcn) Corticosteroids
What || are || the || major || goals || for || sickle || cell || anemia? || - || ✔✔Control || pain, || decreased || episodes || of || crisis, || enhanced || self-esteem || and || power, || increased || knowledge || of || disease || process, || absence || of || complications What || are || the || TB || risk || factors? || - || ✔✔Close || contact || with || someone || who || has || TB, || immunocompromised, || has || other || health || problems, || abuses || alcohol || or || illegal || drugs, || was || not || treated || correctly || for || TB || in || past, || no || adequate || HC, || immigration || from || another || country || with || high || prevalence, || institutionalization, || overcrowded/substandard || housing, || hc || worker || performing || high || risk || jobs What || is || latent || TB? || - || ✔✔Body || able || to || fight || the || bacteria, || stop || it || from || growing, || no || symptoms, || not || infection, || may || become || active || TB || if || triggered What || is || TB || disease/active || TB/ || primary || TB || - || ✔✔Patients || are || sick || and || may || spread || the || disease What || are || the || s/s || of || TB? || - || ✔✔Cough || with || scant || sputum, || chills/fever, || night || sweats, || anorexia/weight || loss, || purulent || blood || tinged || sputum, || dyspnea/chest || pain When || is || extrapulmonary || TB || usually || seen || and || where || in || body? || - || ✔✔Kidney, || GU || tract TB || meningitis TB || of || bone/joints HIV || and || immunocompromised How || is || TB || diagnosed? || - || ✔✔Mantoux || test || (ppd) || Most || definite || test || is || sputum || culture || Can || also || use || cxr, || but || not || definite
What || are || TB || complications? || - || ✔✔TB || empyema, || bronchopleural || fistula, || pneumothorax What || medications || are || used || to || treat || TB? || - || ✔✔Rifampin || and || INH || used || for || 6-12 || months || (compliance || becomes || problem) Also, || pyanzinamide || and || ethambutol What || are || the || side || effects || of || INH || for || TB || treatment? || - || ✔✔Peripheral || neuropathy Hepatitis What || are || the || side || effects || of || rifampin || for || TB || treatment? || - || ✔✔Red-orange || body || fluids, || renal || failure, || thrombocytopenia, || leukopenia, || elevation || of || liver || enzymes What || are || the || side || effects || of || pyanzinamide || for || TB || treatment? || - || ✔✔Hepatitis What || are || the || side || effects || of || ethambutol || for || TB || treatment? || - || ✔✔Optic || neuritis WhAt || is || the || nursing || management || for || TB? || - || ✔✔Promoting || airway || clearance, || adherence || to || treatment || regimen, || promoting || activity || and || nutrition, || preventing || transmission Nursing || assessment || and || monitoring || for || TB? || - || ✔✔Side || effects || of || medications, || monitor || sputum || cultures, || monitor || VS's, || monitor || respiratory || status Modes || of || transmission || for || HIV || - || ✔✔Sexual, || exposure || to || blood, || perinatal What || is || the || key || for || HIV || behaviors || prevention? || - || ✔✔Education
What || is || pep-post || exposure || prophylaxis || for || HIV/AID's || - || ✔✔Treatment || within || 72 || hours || of || exposure, || regime || of || 2-3 || drugs || for || 28'days, || HAART What || is || medical Treatment || may || involve || for || HIV/AID's || - || ✔✔Nutritional || supplements, || vaccinations, || antiviral, || antibiotics, || antidepressants, || chemo/radiation, || antifungals, || interferon, || octreotide || (diarrhea) What || are || the || categories || of || antiretroviral || medications || for || HIV/AID's || - || ✔✔Nucleoside || analog || reverse || transcriptase || inhibitors, || non-nucleoside || ARTI, || protease || inhibitors, || fusion || inhibitors What || are || the || side || effects || of || nucleoside || medications || to || treat || HIV/AID's || - || ✔✔Dizzy, || bone || marrow || suppression, || hepatotoxic, || nephrotoxic, || peripheral || neuropathy, || Abacavir: || allergic || responses What || are || the || side || effects || of || non-nucleoside || medications || to || treat || HIV/AID'S || - || ✔✔HA, || skin || rashes, || abdominal || pain, || hepatotoxic Efavirenz: || dysphoria, || dizzy, || insomnia, || nightmares What || are || the || side || effects || of || protease || inhibitors || for || the || treatment || of || HIV/AID's || - || ✔✔Photosensitivity, || jaundice, || hyperbilirubinemia, || nephrolithiasis/flank || pain, || hyperglycemia/insulin || resistance, || fat || redistribution WhAt || are || the || side || effects || of || the || newest || drug || class || fusion || inhibitors || for || treatment || of || HIV/AID's || - || ✔✔Skin || reaction || at || injection || site ||
Enfuvirtide What || are || other || treatments || that || can || be || used || for || HIV/AIDs || - || ✔✔Bone || marrow || transplantation, || lymphocyte || transfusion, || interleukin || 2 || transfusion What || are || complementary || alternative || therapies || for || HIV/AIDS || - || ✔✔Foods || (astragalus), || echinacea, || vitamin || C Antiviral || foods || (shark || cartilage, || curcumin, || compound || Q, || aloe || Vera What || healthy || lifestyle || choice || can || be || made || to || help || with || HIV\AIDs || - || ✔✔Nutrition || diet, || plenty || of || sleep || and || rest, || exercise || with || moderation, || good || hygiene, || avoiding || exposure || to || illnesses What || complications || can || occurs || with || HIV/AIDs || - || ✔✔Opportunistic || infections, || impaired || breathing/respiratory || failure, || wasting || syndrome, || F&E || imbalance, || adverse || reaction || to || medications || (liver || and || kidney) What || interventions || can || nurses || use || for || HIV/AIDs || - || ✔✔Skin || integrity, || promoting || bowel || pattern, || activity || intolerance, || maintaining || thought || process, || nutrition, || decreased || isolation, || pain || management, || improving || airway || clearance What || teaching || can || be || done || with || HIV/AIDs || - || ✔✔Education || strategies, || compliance || with || medications, || employee || protection || , What || factors || influence || ICP? || - || ✔✔Arterial || pressure, || venous || pressure, || intra-abdominal/thorasic, || posture, || temperature, || blood || gases What || is || cerebral || perfusion || pressure || (CPP)? || - || ✔✔Pressure || needed || to || ensure || blood || flow || to || the || Brain
What || are || nursing || interventions || for || increased || ICP || - || ✔✔Maintain || airway, || assess || LOC, || I&O's, || ICP, || pupillary || responses, || head || in || neutrally || aligned || position, || HOB || 30 || degrees, || hyperventilate || with || suction, || maintain || normal || temp, || stool Softners, || protect || corneas What || is || the || medication || management || for || increased || ICP || - || ✔✔Mannitol || (osmotic || diuretic), || lasix, || decadron, || Dilantin, || antibiotics || (due || to || invasive || brain || procedures), || vasoactive || drugs || for || BP How || is || increased || ICP || diagnosed || - || ✔✔Ct || scan, || ICP || monitoring, || EEG, || angiography, || labs || (electrolytes), || CSF || analysis, || ABG's How || do || you || monitor || increased || ICP || - || ✔✔ICP || monitoring, || ventriculostomy || drain, || subarachnoid || bolt, || Licox || catheter || brain || tissue || oxygenation || monitor Increased || ICP || surgical || side || effects || - || ✔✔Periorbital || edema, || hematoma || formation, || headache Apply || cold || compresses, || HOB || elevated, || notify || dr || if || significant || periorbital || edema, || s/s || Increased || ICP Post-op || management || of || increased || ICP || - || ✔✔Oxygen, || hemodynamics, || ICP || monitoring, || mannitol, || anti-seizure, || decadron, || pain, || labs, || s/s || infection Post-op || nursing || interventions || increased || ICP || - || ✔✔Patent || airway, || oxygen, || HOB || 30-45, || mouth || care, || body || temp, || prevent || infection, || skin || care, || S/S || pain, || dark || and || quiet || environment
Points || to || remember || for || increased || ICP || - || ✔✔Earliest || sign || change || LOC, || Glasgow, || interventions || for || IICP, || Monroe || kelly || hypothesis || (volume || up || pressure || up), || cerebral || perfusion, || medication Which || type || of || stroke || occurs || more || often? || - || ✔✔Hemorrhagic Non-modifiable || risk || factors || of || strokes? || - || ✔✔Age || (over || 65), || African || American, || men Modifiable || risk || factors || for || strokes || - || ✔✔HTN, || heart || disease || (a.fib, || hf, || cardiomyopathy, || carotid || stenosis), || previous || TIA, || elevated || cholesterol/hematocrit, || obesity, || DM, || sleep || apnea, || BC || use, || smoking, || excessive || alcohol/drug || use How || to || dx || a || stroke? || - || ✔✔CT Three || types || of || ischemic || strokes || - || ✔✔TIA, || thrombotic, || embolic What || is || a || TIA || - || ✔✔Temporary || neurological || deficit || resulting || from || a || temporary || impairment || of || blood || flow, || warning || of || impending || stroke, || dx || need || to || tx || and || prevebt || irreversible || deficit Two || types || of || hemorrhagic || strokes || - || ✔✔Intracerebral || Subarachnoid What || is || a || hemorrhagic || stroke || - || ✔✔Brain || metabolism || is || disrupted || by || exposure || to || blood, || increases || ICP || due || to || blood || in || the || subarachnoid || space, || compression || or || secondary || ischemia || from || reduced || perfusion || and || vasoconstriction || causes || injury || to || brain || tissue Clinical || manifestations || of || stroke || - || ✔✔Vary || depending || on || area || of || brain || affected || (location, || size || of || area, || amount || of || collateral || blood || flow)
Antiplatlets Statins Antihypertensive Medical || management || acute || phase || ischemic || strokes || - || ✔✔Prompt || dx/tx Thromblytic || (tpa) Eligibility || for || TPA || with || stroke || - || ✔✔18+, || ischemic || stroke, || 3 || hours || or || less, || not || a || minor || stroke, || no || seizures || at || onset. || No || anticoagulants, || no || intracranial || hemorrhage/neoplasm/anyeursym/Avm, || no || surgery || past || 14 || days, || no || stroke/head || trauma || within || 3 || months, || no || go/gu || bleed || working || 21 || days, || SBP || less || than || 185/dpb || less || than || 110, || INR || less || than || 1. tpA || - || ✔✔0.9mg/kg || (90mg || max) 10% || bolus || then || rest || over || 1hr Must || be || given || less || than || 3 || hours || from || start || of || stroke Most || common || drugs || used || for || acute || phase || ischemic || stroke || - || ✔✔Coumadin, || heparin. || Lovenox Hemorrhagic || stroke || complications || - || ✔✔Rebleed, || hematoma || expansion, || vasospasm || (triple || H || therapy) || , || acute || hydrocephalus Medical || management || of || hemorrhagic || stroke || - || ✔✔Prevent || risk || of || rebleed || and || prevent || complications || Bed || rest || with || sedation Oxygen
FFP || and || or || Vit || K Antiseizures Analgesic || SCD's || Head || of || bed || 30 Control || bleeding Control || BP Decrease || ICP || Evacuate || hematoma Nursing || assessment || for || stoke || - || ✔✔When || did || it || start? || Activity, || progression, || LOC, || gait, || speech, || Vision, || balance, || reading, || medical || HX, || medications, || lifestyle, || past || hx || Acute: || monitor || loc, || vs's, || assess || and || check || for || complications || After || stoke: || rehab Stroke || test || FAST || - || ✔✔face Arms Speech Time How || to || maintain || cerebral || perfusion || with || strokes || - || ✔✔Monitor || respiratory || status, || patent || airway. || Lung || sounds, || o2, || LOC, || strength || and || reflexes, || cardiac, || temp, || I&O, || seizures Promoting || physics
S/S || heat || exhaustion || (dehydration, || over || exposure) || - || ✔✔Lightheadedness, || faintness, || dizziness, || HA, || weakness. || Fatigue, || n\b, || muscle || cramps Heat || exhaustion || treatment || - || ✔✔Recognize || problem, || stop || physical || activity, || move || to || cool || place, || remove || restrictive || clothes, || orally || rehydrate, || cool || water || bath, || may || need || IV || fluids Heat || stroke || s/s Emergency || - || ✔✔High || temp, || mental || status || change,hypotension, || tachycardia, || tachypnea Heat || stroke || treatment || - || ✔✔Rapid || cooling, || prevent || shivering, || prevent || seizures, || death || if || not || treAted Hyperthermia || interventions || - || ✔✔Monitor || vs's, || assess || skin || color || and || temp, || monitor || CBC || (dehydration), || reduce || coverings, || decrease || room || temperature, || increase || fluid || intake,i&o, || antipyretic, || decrease || physical || activity, || tepid || sponge || bath, || cooling || blanket Malignant || hyperthermia || - || ✔✔Potentially || fatal || inherited || disorder || Muscle || rigidity, || dark || brown || urine, || bleeding, || fast || irregular || HR Treatment || for || malignant || hyperthermia || - || ✔✔Non-rebreather, || IV || access, || datrolene || (muscle || relaxant), || decrease || body || temp, || Foley || catheter Hypothermia || s/s || - || ✔✔Mild: || shivering, || muscle || incoordination, || mental || slowness, || tachycardia, || tachypnea Hypothermia || treatment || mild || - || ✔✔Bair || hugger, || warm || blanket, || provide || warm || environment. || Cover || scalp, || heat || lamps
Hypothermia || s/s || moderate || - || ✔✔Temp || 82- Cold || diuresis, || obvious || motor || impairment, || confusion, || apathy, || irrationality, || stupor, || unconsciousness, || depressed || VS Hypothermia || moderate || treatment || - || ✔✔Warm || IV || fluids, || warming || blanket, || heated || oxygen, || heated || gastric || lavage, || handle || carefully, || watch || for || after || drop Hypothermia || severe || - || ✔✔Under || 82, || cardiac || arrest || Tx || cardiopulmonary || bypass, || hemodialysis. || Must || be || warmed || to || determine || death Thermoregulation || and || newborns || - || ✔✔Large || surface || area. || Preemie || vs || normal(body || fat || and || muscle), || brown || fat, || lose || heat || fast, || do || not || shiver, || less || muscle || mass Thermoregulation || with || elderly || - || ✔✔Anatomy, || chemical, || hormonal, || sensory, Clothing, || culture, || environment Principles || of || hospice || care || - || ✔✔Death || must || be || accepted, || managed || by || team, || pain || managed, || patient || and || family || one || unit, || bereavement || care || for || family, || research || and || education Barriers || to || improving || end || of || life || care || - || ✔✔Cure=focus || of || health || care || establishment, || financial || criteria, || cultural/social || issues, || discomfort || with || addressing || death, || psychological/coping || responses || to || death End || of || life || communication || - || ✔✔Reflect || on || on || experiences, || deliver/interpret || info || without || hiding || behind || medical || words, || realize || best || time || patient || may || want || to || talk || may || not || be || your
